🎁 Black Friday: up to 50% off of annual plans
Y-Biologics, Inc. (KOSDAQ:338840)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,670.00
-540.00 (-6.58%)
At close: Nov 20, 2026

Y-Biologics Revenue

Y-Biologics had revenue of 1.55B KRW in the quarter ending June 30, 2026, with 32.85% growth. This brings the company's total for the last twelve months to 3.17B, down -46.81% year-over-year. In the year 2025, Y-Biologics had annual revenue of 2.91B, down -49.45%. That makes Y-Biologics the 42,081st largest company in the world by revenue and 2,563rd in South Korea.

Revenue (ttm)
3.17B
Revenue Growth
-46.81%
P/S Ratio
37.18
Revenue / Employee
n/a
Employees
n/a
Market Cap
117.86B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.91B-2.85B-49.45%
Dec 31, 20245.76B2.28B65.64%
Dec 31, 20233.48B-671.48M-16.18%
Dec 31, 20224.15B-696.78M-14.37%
Dec 31, 20214.85B-1.88B-27.99%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Cell Biotech60.40B
ISU Abxis51.04B
Genome & Company24.46B
NIBEC21.93B
Bio Solution18.00B
TiumBio15.68B
curacle co.,ltd.8.24B
Kangstem Biotech3.16B
Revenue Rankings